Potential Boon For Pancreatic Cancer at Johns Hopkins Medical
Share this Article:
June 23, 2014
During irreversible electroporation (IRE), treatment options once considered impossible for pancreatic cancer are revealed. Johns Hopkins surgeons are increasingly finding that once-thought unresectable pancreatic cancer is sometimes resectable. In 2012, surgery team director Chris Wolfgang and surgical oncologist Matthew Weiss started offering an additional therapy for unresectable, locally advanced pancreatic cancers. Called irreversible electroporation (IRE), the treatment has proven effective for liver cancer and is now being used at The Johns Hopkins Hospital for pancreatic cancer.